Exact Sciences Cor (EXAS) Stock Price, Quote & News

Company Profile

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 608 284 5700

Website: www.exactsciences.com

Address:

5505 Endeavor Lane, Madison, United States

Tippmann98 Aug. 6 at 8:37 PM

$ROOT weird market, $UPST double beat stock way down. $EXAS double beat also way down. ….

0 · Reply

SaylorsPonz Aug. 6 at 8:34 PM

$EXAS options tout didnt appreciate questioning the cherry picked after the fact (AFTER it tanked) flex by them ps, the trade was a spread so they blocked me. lol. I may never recover

0 · Reply

Sykes Aug. 6 at 8:26 PM

$EXAS Vegas style?

0 · Reply

InvestinRedemption Aug. 6 at 8:23 PM

$EXAS This price action is feeling it’s colon 💩 😬

0 · Reply

jschwab1978 Aug. 6 at 8:23 PM

$EXAS I bought a small amount more on the big sudden drop, but hesitated to go too far without knowing what was causing it. Now it's climbing back up really fast. Hopefully earnings will be ok.

1 · Reply

nUme22 Aug. 6 at 8:20 PM

$EXAS I have been busy... Give me some below 35 , missed the 34s...maybe tomorrow

0 · Reply

Ford150 Aug. 6 at 8:19 PM

$EXAS scooped up 500+ shares sub 37

1 · Reply

nUme22 Aug. 6 at 8:18 PM

$EXAS mid term, could soar. But tomorrow could see below 30

0 · Reply

nUme22 Aug. 6 at 8:16 PM

$EXAS what an earning.. seesh more like whooping. $GH took it near term

1 · Reply

Kleeno Aug. 6 at 8:15 PM

$EXAS Deal with Freenome to market THEIR blood test???!!!! What happened to OURS???!!!!

1 · Reply

Exact Sciences Announces Second Quarter 2025 Results

Aug 6, 2025, 4:05 PM EDT - 36 minutes ago

Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests

Jul 31, 2025, 7:00 AM EDT - 6 days ago

Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test

Jul 14, 2025, 6:00 AM EDT - 23 days ago

Exact Sciences Schedules Second Quarter 2025 Earnings Call

Jul 10, 2025, 11:19 AM EDT - 27 days ago

Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences' '781 Patent

Jul 9, 2025, 6:00 AM EDT - 4 weeks ago

Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer

May 28, 2025, 6:05 AM EDT - 2 months ago

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

May 27, 2025, 4:05 PM EDT - 2 months ago

Exact Sciences to Participate in June Investor Conference

May 22, 2025, 5:05 PM EDT - 2 months ago

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

May 12, 2025, 10:00 AM EDT - 3 months ago

Exact Sciences Earns 2025 Great Place To Work® Certification™

May 2, 2025, 12:52 PM EDT - 3 months ago

Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling

May 2, 2025, 9:18 AM EDT - 3 months ago

Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance

May 2, 2025, 6:00 AM EDT - 3 months ago

Exact Sciences to Participate in May Investor Conference

May 1, 2025, 8:47 PM EDT - 3 months ago

Exact Sciences Corporation (EXAS) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:05 PM EDT - 3 months ago

Exact Sciences Announces First-Quarter 2025 Results

Apr 29, 2025, 6:59 AM EDT - 3 months ago

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Apr 22, 2025, 6:00 AM EDT - 3 months ago

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

Apr 14, 2025, 6:00 AM EDT - 4 months ago

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Apr 1, 2025, 6:00 AM EDT - 4 months ago

Exact Sciences Schedules First Quarter 2025 Earnings Call

Mar 31, 2025, 6:00 AM EDT - 4 months ago

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

Mar 12, 2025, 9:00 AM EDT - 5 months ago

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

Mar 12, 2025, 5:00 AM EDT - 5 months ago

New Data Highlight the Positive Impact of Exact Sciences' Oncotype DX® Test on Patient Care and Healthcare Efficiency

Feb 24, 2025, 6:00 AM EST - 5 months ago

Exact Sciences to Participate in March Investor Conferences

Feb 24, 2025, 12:16 AM EST - 5 months ago

Exact Sciences: A Strong Q4 Reveals Signs Of A Potential Inflection Point

Feb 19, 2025, 8:37 PM EST - 5 months ago

Exact Sciences Corporation (EXAS) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 4:05 PM EST - 5 months ago

Exact Sciences Announces Fourth Quarter 2024 Results

Feb 18, 2025, 7:05 AM EST - 6 months ago

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy's Petition Challenging Validity of a Second Patent Asserted by Exact Sciences

Feb 5, 2025, 8:00 AM EST - 6 months ago

Flatiron Health and Exact Sciences Partner to Advance Clinical Evidence Generation for Molecular Residual Disease Testing

Feb 3, 2025, 6:00 AM EST - 6 months ago

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

Jan 21, 2025, 5:05 PM EST - 7 months ago

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium

Jan 21, 2025, 5:05 PM EST - 7 months ago

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients

Jan 13, 2025, 1:04 PM EST - 7 months ago

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market

Jan 12, 2025, 7:00 PM EST - 7 months ago

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Jan 2, 2025, 6:00 AM EST - 7 months ago

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Dec 9, 2024, 10:01 AM EST - 8 months ago

AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates

Dec 4, 2024, 11:06 AM EST - 8 months ago

Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

Dec 3, 2024, 12:02 PM EST - 8 months ago

Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)

Dec 2, 2024, 9:30 AM EST - 8 months ago

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Nov 26, 2024, 1:24 PM EST - 9 months ago

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Nov 26, 2024, 12:21 PM EST - 9 months ago

Why Is Exact Sciences Stock Trading Higher On Monday?

Nov 26, 2024, 6:00 AM EST - 9 months ago

Exact Sciences to Participate in December Investor Conferences

Nov 25, 2024, 5:35 PM EST - 9 months ago

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

Nov 19, 2024, 4:07 PM EST - 9 months ago

Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)

Nov 18, 2024, 8:00 AM EST - 9 months ago

Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community

Nov 13, 2024, 1:00 PM EST - 9 months ago

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy

Nov 10, 2024, 11:39 AM EST - 9 months ago

Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.

Nov 6, 2024, 12:36 PM EST - 9 months ago

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount

Nov 6, 2024, 10:13 AM EST - 9 months ago

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point

Nov 6, 2024, 7:58 AM EST - 9 months ago

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HMC SMCI

Nov 5, 2024, 9:06 PM EST - 9 months ago

Exact Sciences Corporation (EXAS) Q3 2024 Earnings Call Transcript

Tippmann98 Aug. 6 at 8:37 PM

$ROOT weird market, $UPST double beat stock way down. $EXAS double beat also way down. ….

0 · Reply

SaylorsPonz Aug. 6 at 8:34 PM

$EXAS options tout didnt appreciate questioning the cherry picked after the fact (AFTER it tanked) flex by them ps, the trade was a spread so they blocked me. lol. I may never recover

0 · Reply

Sykes Aug. 6 at 8:26 PM

$EXAS Vegas style?

0 · Reply

InvestinRedemption Aug. 6 at 8:23 PM

$EXAS This price action is feeling it’s colon 💩 😬

0 · Reply

jschwab1978 Aug. 6 at 8:23 PM

$EXAS I bought a small amount more on the big sudden drop, but hesitated to go too far without knowing what was causing it. Now it's climbing back up really fast. Hopefully earnings will be ok.

1 · Reply

nUme22 Aug. 6 at 8:20 PM

$EXAS I have been busy... Give me some below 35 , missed the 34s...maybe tomorrow

0 · Reply

Ford150 Aug. 6 at 8:19 PM

$EXAS scooped up 500+ shares sub 37

1 · Reply

nUme22 Aug. 6 at 8:18 PM

$EXAS mid term, could soar. But tomorrow could see below 30

0 · Reply

nUme22 Aug. 6 at 8:16 PM

$EXAS what an earning.. seesh more like whooping. $GH took it near term

1 · Reply

Kleeno Aug. 6 at 8:15 PM

$EXAS Deal with Freenome to market THEIR blood test???!!!! What happened to OURS???!!!!

1 · Reply

nUme22 Aug. 6 at 8:14 PM

$GH $EXAS lost, GH gained.. you're welcome

0 · Reply

erich006 Aug. 6 at 8:13 PM

$EXAS mind boggling. If I had extra cash I’d scoop. No way stays down in $30S long

0 · Reply

Ford150 Aug. 6 at 8:12 PM

$EXAS picked up some on that 25% drop

0 · Reply

legalmanABC Aug. 6 at 8:12 PM

$EXAS yikes.

0 · Reply

ChristopherBrecher Aug. 6 at 8:11 PM

$EXAS Another one with unusual put activity.

1 · Reply

Tigerrouse111 Aug. 6 at 8:11 PM

$EXAS What happened?

1 · Reply

blocktrade Aug. 6 at 8:11 PM

$EXAS so done with this pig

0 · Reply

BullYa Aug. 6 at 8:10 PM

$EXAS holy smokes 🔥

1 · Reply

nUme22 Aug. 6 at 8:10 PM

$EXAS wow.. Massacre

0 · Reply

investorjustin Aug. 6 at 8:09 PM

$EXAS ???

1 · Reply

Ford150 Aug. 6 at 7:01 PM

$EXAS a little over 2k today into earnings under $48

0 · Reply

Talbytron Aug. 6 at 6:59 PM

$EXAS big insider accumulation over the past 6 months and a 5 year triangle and first ever positive EPS estimate

0 · Reply

Market Cap	8.83B
Revenue (ttm)	2.76B
Net Income (ttm)	-1.03B
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	298.50
Profit Margin	-37.29%
Debt to Equity Ratio	0.00

Volume	3,759,513
Avg Vol	2,779,770
Day's Range	N/A - N/A
Shares Out	188.64M
Stochastic %K	34%
Beta	0.93
Analysts	Strong Sell
Price Target	$68.55